AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. DNA
  4. [144] Ginkgo Bioworks Holdings, Inc. SEC Filing

[144] Ginkgo Bioworks Holdings, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Filing content is currently unavailable.

Source:

Stock DNA logo
Ginkgo Bioworks Holdings Inc

NYSE:DNA

DNA Rankings

#2945 Ranked by Market Cap
N/A Ranked by Dividends

DNA Latest News

Aug 29, 2025
Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions
Aug 20, 2025
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry
Aug 12, 2025
Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth
Aug 7, 2025
Ginkgo Bioworks Reports Second Quarter 2025 Financial Results
Jul 31, 2025
Ginkgo Bioworks Announces Date of Second Quarter 2025 Results Presentation

DNA Latest SEC Filings

Aug 29, 2025
[8-K] Ginkgo Bioworks Holdings, Inc. Reports Material Event
Aug 26, 2025
[Form 4] Ginkgo Bioworks Holdings, Inc. Insider Trading Activity
Aug 7, 2025
[S-3] Ginkgo Bioworks Holdings, Inc. Shelf Registration Statement
Aug 7, 2025
[10-Q] Ginkgo Bioworks Holdings, Inc. Quarterly Earnings Report
Aug 7, 2025
[8-K] Ginkgo Bioworks Holdings, Inc. Reports Material Event

DNA Stock Data

731.12M
55.40M
6.77%
79.18%
13.94%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
BOSTON